12.00 Addressing the Safety Concerns of Cisterna Magna Injections to Mitigate Brainstem Injury & Toxicity Risks
Time: 12:00 pm
day: Day One Track 2 AM
Details:
- Alleviating risks of localized toxicity associated with ICM administration in the clinic
- Identifying the optimal dosage window for therapeutics delivered by ICM to achieve desired expression levels in the target of interest
- Assessing the feasibility of ICM in clinical practice across different patient populations
